SCHEMBL9937518

SCHEMBL9937518

Cc1cccc(C)c1C(=O)Oc1ccc2c(ccc3c4c(ccc32)C=CC4)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.38
MEN1 O00255 4/20 0.38
CASP3 P42574 2/20 0.38
SENP8 Q96LD8 2/20 0.38
SENP7 Q9BQF6 2/20 0.38
SENP6 Q9GZR1 2/20 0.38
NPC1 O15118 1/20 0.38
ESR1 P03372 3/20 0.35
MAPT P10636 5/20 0.34
TDP1 Q9NUW8 3/20 0.34
ALDH1A1 P00352 4/20 0.34
GAA P10253 3/20 0.34
KDM4E B2RXH2 2/20 0.34
GLA P06280 2/20 0.34
NPBWR1 P48145 1/20 0.34
F2 P00734 1/20 0.33
PLA2G1B P04054 1/20 0.32
ATG4B Q9Y4P1 1/20 0.32
MMP1 P03956 2/20 0.32
MMP12 P39900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9937599 0.88 KMT2A (0.53) KMT2AMEN1CASP3SENP8SENP7
SCHEMBL669403 0.83 KMT2A (0.55) KMT2AMEN1ESR1MAPTTDP1
SCHEMBL996026 0.82 CA12 (0.41) KMT2AMEN1MAPTTDP1ALDH1A1
SCHEMBL668901 0.82 CA12 (0.41) KMT2AMEN1MAPTTDP1ALDH1A1
SCHEMBL9937653 0.80 KMT2A (0.37) KMT2AMEN1CASP3SENP8SENP7
SCHEMBL23199773 0.80 HSD17B10 (0.44) KMT2AMEN1CASP3SENP8SENP7
SCHEMBL9938547 0.79 KDM4E (0.40) KMT2ANPC1ESR1MAPTALDH1A1
SCHEMBL9938614 0.79 MEN1 (0.42) KMT2AMEN1
SCHEMBL9938274 0.79 ELANE (0.38) TDP1ALDH1A1HSD17B10L3MBTL1HPGD
SCHEMBL9937557 0.79 MAPT (0.41) KMT2AMEN1CASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651916-A2 C-17-HETEROARYL STEROIDAL COMPOUNDS AS INHIBITORS OF CYP11B, CYP17, AND/OR CYP21 BioMarin Pharmaceutical Inc. (US) 2013-10-23 EP disclosed
WO-2012083112-A2 CYP11B, CYP17, AND/OR CYP21 INHIBITORS BIOMARIN PHARMACEUTICAL INC. (US) 2012-06-21 WO disclosed